Learn more

BAYER CORP

Overview
  • Total Patents
    852
  • GoodIP Patent Rank
    215,912
About

BAYER CORP has a total of 852 patent applications. Its first patent ever was published in 1990. It filed its patents most often in Canada, EPO (European Patent Office) and Mexico. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are MERCK & CO INC, ELAN PHARM INC and PHARMACIA & UPJOHN CO LTD.

Patent filings per year

Chart showing BAYER CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Khire Uday 64
#2 Smith Roger A 61
#3 Dumas Jacques 58
#4 Scott William J 57
#5 Wood Jill E 55
#6 Riedl Bernd 50
#7 Sibley Robert N 39
#8 Cho Myung-Sam 34
#9 Renick Joel 34
#10 Lowinger Timothy B 32

Latest patents

Publication Filing date Title
JP2010065047A Raf kinase inhibitor
BRPI0704418A2 polyether polyols based on cashew nut liquid, a process for the production of these polyether polyols, flexible foams produced from these polyether polyols, and a process for the production of these foams
WO2007124159A2 System and method for in situ measurements
AU2006201959A1 Inhibition of Raf Kinase using Substituted Heterocyclic Ureas
CN1824796A Quantitation of enzyme activity using planar waveguide
US2006051830A1 Quantitation of enzyme activity using planar waveguides
US2005043237A1 Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
CA2436003A1 Two-component coating compositions containing silane adhesion promoters
TW200407347A Moisture-curable, polyether urethanes with reactive silane groups and their use as sealants, adhesives and coatings
TW200415163A Polyether urethanes containing one reactive silane group and their use in moisture-curable polyether urethanes
TW200404831A Moisture-curable, polyether urethanes with reactive silane groups and their use as sealants, adhesives and coatings
AU2003204708B2 Inhibition of Raf Kinase using Substituted Heterocyclic Ureas
TW200417557A Moisture-curable, polyether urethanes with reactive silane groups and their use as sealants, adhesives and coatings
TW200404837A Moisture-curable, polyether urethanes with reactive silane groups and their use as sealants, adhesives and coatings
MY138267A Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
US7094811B2 Energy absorbing flexible foams produced in part with a double metal cyanide catalyzed polyol
US7157056B2 Sample introduction device
US7163616B2 Reagents and methods for detecting analytes, and devices comprising reagents for detecting analytes
AU2002300223B2 Mechanical Mechanism for a Blood Glucose Sensor Dispensing Instrument
EP1264850A1 Polyurethane foams having improved heat sag and a process for their production